Paul Holtzheimer, M.D.
2016 NARSAD Independent Investigator Grantee
Paul Holtzheimer, M.D.
Paul Holtzheimer, M.D., Dartmouth-Hitchcock Medical Center, will try to distinguish between two kinds of treatment-resistant depression to better tailor treatments to symptoms. He will look at a population whose depression has not improved in response to typical treatments. Dr. Holtzheimer predicts refractory depression is rooted in one of two distinct brain areas, requiring two distinct kinds of treatment. His team will test this idea by applying transcranial magnetic stimulation (TMS), an alternative treatment, to the two different brain areas in people with depression and then measuring how it affects their symptoms and behavior.
Learn More About the Foundation
Who
We Are
The Brain & Behavior Research Foundation is a global nonprofit organization focused on improving the understanding, prevention and treatment of psychiatric and mental illnesses.
Our
Impact
Beginning in 1987, the Brain & Behavior Research Foundation was providing seed money to neuroscientists to invest in “out of the box” research that the government and other sources were unwilling to fund. Today, Brain & Behavior Research Foundation is still the leading, private philanthropy in the world in this space.
Our
People
Meet the people who make up the Brain & Behavior Research Foundation. Our staff of experts, passionate Board of Directors, and Scientific Council which includes Nobel prize winners and chairs of psychiatric departments around the world.
Annual Report
& Financials
We take our responsibility to our donors seriously and believe that our financial operations must be transparent. We're proud to say that 100% of your contribution for research is invested directly in research grants.
Media
Center
The latest news on brain and behavior research and issues that matter most to you.